A short duration interview based study conducted on the Chronic Myeloid Leukemia patients at single site in order to determine the compliance / adherence to their medication Imatinib Mesylate and to find out the factors causing the non compliance / non adherence to the Imatinib Mesylate
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Chronic Myeloid LeukemiaHealth Condition 2: C921- Chronic myeloid leukemia, BCR/ABL-positive
- Registration Number
- CTRI/2013/02/003427
- Lead Sponsor
- Jyotsna Kapoor
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
1. willing to consent for participation in the study.
2. Patients diagnosed with CML atleast 3 months from the start of the study.
3.Treatment with Imatinib
4. Those who can understand Hindi or English
Exclusion Criteria
1. Patients who are either Dumb or deaf
2. patients who have undergone allogenic stem cell transplantation
3. patients taking another tyrosine kinase inhibitors besides Imatinib Mesylate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method